Severe Cutaneous Adverse Reactions Related to Systemic Antibiotics

被引:78
|
作者
Lin, Ying-Fang [1 ]
Yang, Chih-Hsun [2 ,3 ,4 ,5 ]
Sindy, Hu [1 ,5 ]
Lin, Jing-Yi [2 ,3 ,4 ,5 ]
Hui, Chung-Yee Rosaline [2 ,3 ,4 ,5 ]
Tsai, Yun-Chen [2 ,3 ,4 ]
Wu, Ting-Shu [6 ]
Huang, Ching-Tai [6 ]
Kao, Kuo-Chin [5 ,7 ]
Hu, Han-Chung [5 ,7 ]
Chiu, Cheng-Hsun [8 ]
Hung, Shuen-Iu [9 ]
Chung, Wen-Hung [2 ,3 ,4 ,5 ]
机构
[1] Chang Gung Mem Hosp, Dept Dermatol, Taoyuan, Taiwan
[2] Chang Gung Mem Hosp, Dept Dermatol, Drug Hypersensit Clin & Res Ctr, Taipei 10507, Taiwan
[3] Chang Gung Mem Hosp, Drug Hypersensit Clin & Res Ctr, Dept Dermatol, Linkou, Taiwan
[4] Chang Gung Mem Hosp, Drug Hypersensit Clin & Res Ctr, Dept Dermatol, Keelung, Taiwan
[5] Chang Gung Univ, Coll Med, Taoyuan, Taiwan
[6] Chang Gung Mem Hosp, Div Infect Dis, Linkou, Taiwan
[7] Chang Gung Mem Hosp, Dept Thorac Med, Linkou, Taiwan
[8] Chang Gung Mem Hosp, Dept Pediat, Div Pediat Infect Dis, Linkou, Taiwan
[9] Natl Yang Ming Univ, VYM Genome Res Ctr, Infect & Immun Res Ctr, Inst Pharmacol,Sch Med, Taipei 112, Taiwan
关键词
SCARs; systemic antibiotics; TOXIC EPIDERMAL NECROLYSIS; STEVENS-JOHNSON-SYNDROME; IGE-MEDIATED HYPERSENSITIVITY; BETA-LACTAM ANTIBIOTICS; CROSS-REACTIVITY; IMMEDIATE HYPERSENSITIVITY; ERYTHEMA MULTIFORME; TEICOPLANIN; VANCOMYCIN; PENICILLINS;
D O I
10.1093/cid/ciu126
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Systemic antibiotics are a major cause of severe cutaneous adverse reactions (SCARs). The selection of alternative antibiotics and management for SCARs patients with underlying infections can be challenging. Methods. We retrospectively analyzed 74 cases of SCARs, including Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), drug rash with eosinophilia and systemic symptoms (DRESS), and acute generalized exanthematous pustulosis (AGEP), related to use of systemic antibiotics in Taiwan from January 2006 to January 2012. We analyzed the causative antibiotics, clinical features, organ involvements, and mortality. We also assessed patient tolerability to alternative antibiotics after the development of antibiotic-related SCARs. Results. The most common causes of SCARs were penicillins and cephalosporins for SJS/TEN and AGEP; glycopeptides for DRESS. Fatality was more frequent in the SJS/TEN group. In patients with SJS/TEN, higher mortality was associated with old age and underlying sepsis before the development of SCARs. The majority of patients with penicillin-or cephalosporin-related SCARs were able to tolerate quinolones, glycopeptides, and carbapenems. Conclusions. Complicated underlying conditions and infections may increase mortality in patients with antibiotic-related SCARs. The selection of structurally different alternative drugs is important to avoid recurrence.
引用
收藏
页码:1377 / 1385
页数:9
相关论文
共 50 条
  • [21] Markers of systemic involvement and death in hospitalized cancer patients with severe cutaneous adverse reactions
    Mori, Shoko
    Hickey, Alanna
    Dusza, Stephen W.
    Lacouture, Mario E.
    Markova, Alina
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 80 (03) : 608 - 616
  • [22] Genetic Variants Associated With Phenytoin-Related Severe Cutaneous Adverse Reactions
    Chung, Wen-Hung
    Chang, Wan-Chun
    Lee, Yun-Shien
    Wu, Ying-Ying
    Yang, Chih-Hsun
    Ho, Hsin-Chun
    Chen, Ming-Jing
    Lin, Jing-Yi
    Hui, Rosaline Chung-Yee
    Ho, Ji-Chen
    Wu, Wei-Ming
    Chen, Ting-Jui
    Wu, Tony
    Wu, Yih-Ru
    Hsih, Mo-Song
    Tu, Po-Hsun
    Chang, Chen-Nen
    Hsu, Chien-Ning
    Wu, Tsu-Lan
    Choon, Siew-Eng
    Hsu, Chao-Kai
    Chen, Der-Yuan
    Liu, Chin-San
    Lin, Ching-Yuang
    Kaniwa, Nahoko
    Saito, Yoshiro
    Takahashi, Yukitoshi
    Nakamura, Ryosuke
    Azukizawa, Hiroaki
    Shi, Yongyong
    Wang, Tzu-Hao
    Chuang, Shiow-Shuh
    Tsai, Shih-Feng
    Chang, Chee-Jen
    Chang, Yu-Sun
    Hung, Shuen-Iu
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 312 (05): : 525 - 534
  • [23] Adverse cutaneous reactions (ACR) to antibiotics causative agents
    Grigoreas, C
    Vourdas, D
    Petalas, K
    Karamalakis, V
    Theocharis, S
    ALLERGY, 2002, 57 : 256 - 256
  • [25] Treatment of severe cutaneous adverse drug reactions
    Ingen-Housz-Oro, S.
    Duong, T-A
    de Prost, N.
    Colin, A.
    Fardet, L.
    Lebrun-Vignes, B.
    Barbaud, A.
    Chosidow, O.
    Wolkenstein, P.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2018, 145 (6-7): : 454 - 464
  • [26] Chemokines in Severe Cutaneous Adverse Reactions (SCARs)
    Miyagawa, Fumi
    Asada, Hideo
    BIOMOLECULES, 2021, 11 (06)
  • [27] Recognising severe cutaneous adverse drug reactions
    Chee, Paul
    MEDICAL JOURNAL OF AUSTRALIA, 2017, 207 (08) : 325 - +
  • [28] Bronchopulmonary involvement in severe cutaneous adverse reactions
    de Prost, N.
    Mekontso-Dessap, A.
    Valeyrie-Allanore, L.
    Maitre, B.
    REANIMATION, 2013, 22 (01): : 73 - 79
  • [29] Genetic markers of severe cutaneous adverse reactions
    Jung, Jae-Woo
    Kim, Jae-Yeol
    Park, In-Won
    Choi, Byoung-Whui
    Kang, Hye-Ryun
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2018, 33 (05): : 867 - 875
  • [30] In the pursuit of classifying severe cutaneous adverse reactions
    Wolf, Ronni
    Wolf, Danny
    Davidovici, Batya
    CLINICS IN DERMATOLOGY, 2007, 25 (03) : 348 - 349